Sentences with phrase «treat hepatitis»

Viekira Pak and Technivie are prescribed to some people to treat hepatitis C, but last October, the FDA issued a warning that these drugs have been linked to liver injuries in patients with a history of liver disease.

A margin of safety is created by: (i) approximately $ 6.50 of cash (net of convertible notes outstanding); (ii) a royalty stream from PEGINTRON, a drug used to treat hepatitis C marketed by Merck, with an after - tax present value of approximately $ 3.50, which Enzon is currently attempting to sell; and (iii) a royalty stream from CIMZIA, a drug approved to treat arthritis and Crohn's disease marketed by UCB Pharma, with an after - tax present value of approximately $ 1.50.

Zadaxin ® is used to treat hepatitis B and C, and has been studied extensively for its ability to support an immune system that has been suppressed by chemotherapy in cancer patients.

The number of drugs that treat hepatitis C have increased in recent years.

Those breakthroughs include the development of new screening methods to search for effective drugs, new ways to treat hepatitis B using different approaches to shut down the virus, a new blood biomarker that aids in the early detection of liver cancer, and a promising drug that selectively kills liver cancer cells in animal studies.

(Tuesday, March 21, 2017 - Toronto)- A pilot study of a class of drugs used to treat hepatitis and some forms of multiple sclerosis has been shown for the first time to ease symptoms of Ebola patients, while also increasing their survival.

A modeling study by Massachusetts General Hospital (MGH) investigators finds that the availability of directly - acting antiviral (DAA) drugs to treat hepatitis C virus (HCV) infection could allow the transplantation of livers from HCV - positive...

(HealthDay)-- Technivie (ombitasvir, paritaprevir and ritonavir) has been approved by the U.S. Food and Drug Administration, in tandem with ribavirin, to treat hepatitis C genotype 4 infection among people without poor liver...

Consider a 1993 trial of a drug to treat hepatitis B.

While a new generation of safer, more effective oral medications to treat hepatitis C patients may cost tens of thousands of dollars for a 12 - week regiment, investing in these new therapies could generate savings estimated at more than $ 3.2 billion annually in the U.S. and five European countries, according to a new study (abstract 228) released today at Digestive Disease Week ® (DDW) 2015.

To address these concerns, the US Food and Drug Administration's Division of Antiviral Products in the Center for Drug Evaluation and Research (CDER) has published a paper that highlights the agency's scientific approaches and regulatory processes that support the development and approval of promising drugs to treat hepatitis C.

The committee was split evenly on whether the development of a vaccine to prevent hepatitis C would also meet the standard, but agreed that under the criteria neither development of a therapeutic vaccine nor of drugs to treat hepatitis C could justify the use of chimpanzees.

Interferon - a, a drug widely used to treat hepatitis C and several cancers, may also work against SARS, according to a study published online this week by Nature Medicine.

Researchers then used these predictive models to understand — at the metabolic level — why some individuals experienced side effects to ribavirin, a drug used to treat hepatitis C, while other individuals did not.

«Drugs approved to treat hepatitis C and compounds in development to treat other viral diseases are prime candidates to use against the Zika virus,» Kao said.

Since the early 1990s, treating hepatitis C has been a harsh and tedious process, with somewhat hit - or - miss results.

Although such harvested cells could be cultured as say, liver cells for treating hepatitis or dopamine - producing cells for Parkinson's, the resulting transplants would likely be rejected by patients» immune systems.

A promising new avenue for treating hepatitis B has been reported by researchers at Hiroshima University who have developed a new animal model of the disease.

«New Chinese herbal medicine has significant potential in treating hepatitis C, study suggests.»

This new work suggests that anti-PD-1 antibodies might be equally effective in treating hepatitis C and other persistent human viral infections, says Christopher Walker, PhD, a senior author on the study and director of the Center for Vaccines and Immunity at Nationwide Children's.

(NaturalHealth365) Traditionally speaking, dandelion greens have been used for medicinal purposes; treating hepatitis; kidney disease and liver disorders, such as jaundice and cirrhosis.

The last section of the article tells the story of my client, Jean Lin, who was denied payment on the life insurance policy of her husband when it was discovered that his successfully treated hepatitis B — a condition that is common in the Asian population — was not disclosed in the application.

Not exact matches

The news underlines a larger trend of a promising new class of drugs that could fundamentally shift the way hepatitis C is treated.

Called DCV Dual Regimen, the therapy combines daclatasvir and asunaprevir to treat one genotype of chronic hepatitis C.

«But unlike hepatitis C, they are treating patients that only have weeks or months to live and providing durable remissions.»

This California biotech serves the world with medicines to treat HIV / AIDS, hypertension, hepatitis and other conditions.

In collaboration with Indiana University and the National Institute on Alcohol Abuse and Alcoholism (NIAAA), Intercept is supporting a blinded Phase 2 trial treating 60 patients with alcoholic hepatitis (NCT02039219 on clinicaltrials.gov).

Lactoferrin is used for treating stomach and intestinal ulcers, diarrhea, and hepatitis C.

An organic chemist based at Emory University in Atlanta who has helped start several biotech companies, Schinazi has made hundreds of millions of dollars from the drugs, which treat HIV and hepatitis B and help cure hepatitis C.

The researchers also found that treating the mice with a molecule called CTL - associated antigen - 4 immunoglobulin (CTLA4Ig) suppressed damage to liver cells infected with hepatitis B virus, suggesting that this might be a potential approach to treatment.

WELL - TREATED Kidneys from hepatitis C - positive donors were successfully transplanted into 10 uninfected patients.

She and colleagues treated 10 patients who received hepatitis C - positive kidneys with the new drug regimens.

A 12 - week dose of an investigational three - drug hepatitis C combination cleared the virus in 93 percent of patients with liver cirrhosis who hadn't previously been treated, according to a study in the May 5, 2015, issue of The Journal of the American Medical Association.

An affordable hepatitis C combination treatment including the new drug candidate ravidasvir has been shown to be safe and effective, with extremely high cure rates for patients, including hard - to - treat cases, according to interim results from the Phase II / III STORM - C - 1 trial presented by the non-profit research and development organisation Drugs for Neglected Diseases initiative (DNDi) at the International Liver Conference in Paris.

Genotype 1 is the most common, but hardest to treat, strain of the hepatitis C virus.

Both antivirals are routinely used together to treat viral diseases such as hepatitis C.

A new combination therapy allows chronic hepatitis C to be treated in a manner that is less aggressive yet equally efficient.

Recommendations include making sure health teams are disease free before they enter an area, treating illnesses, and vaccinating newly contacted people, giving priority to flu, measles, and hepatitis B, he said.

«The cohort study has found that the sofosbuvir / daclatasvir combination is associated with a high rate of SVR4 in difficult - to - treat patients infected by genotype - 1 hepatitis C.

«There are many people who don't know that they have the infection, don't have access to hepatitis C care and medications, and who haven't been treated.

We're nearly ready to use CRISPR to change DNA inside our own bodies to treat many disorders, from hepatitis B to muscular dystrophy

Financial Resistance Because the soon to be released combination pill cures hepatitis in just 12 weeks — eliminating the need for and the expense of treating an otherwise chronic illness — it may end up costing less overall than previous treatments.

«FDA addresses concerns on approval of drugs to treat chronic hepatitis C.» ScienceDaily.

It is worthwhile to give patients expensive new drugs that can cure their hepatitis C much earlier than some insurers are now willing to pay for them, according to a UC San Francisco study that models the effects of treating the disease early versus late in its development.

In the U.S., we spend more than $ 140 billion a year treating cancer, often with less health benefit than is provided by the new hepatitis C treatments.»

New research announced at the International Liver CongressTM 2014 today provides new hope for the notoriously difficult - to - treat population of liver transplant patients with recurring hepatitis C (HCV).

Researchers used data collected from more than 1,900 chronic hepatitis C patients treated with LDV / SOF, which has a cure rate of between 94 and 99 percent with minimal side effects.

The team investigated an antiviral drug called sofosbuvir, approved and marketed under the brand name Sovaldi to treat and cure hepatitis C infections.

Using sofosbuvir - ledipasvir, which is sold as Harvoni, and is one several new drugs for hepatitis C, researchers compared the costs of treating patients at all stages of fibrosis, zero through four, with the cost of waiting until stages three or four, which is when some patients are usually treated.

The penicillin - based antibiotics used to treat the infection can also cause side effects such as stomach upsets, rashes and even hepatitis in some rare cases.